Rennova Health, Inc. (RNVA) financial statements (2021 and earlier)
Company profile
| Business Address |
400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH, FL 33401 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 8062 - General Medical and Surgical Hospitals (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 9/30/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 0 | 0 | 0 | 9 | ||||
| Cash and cash equivalents | 0 | 0 | 0 | 9 | ||||
| Receivables | 4 | 4 | 3 | 3 | 11 | |||
| Inventory, net of allowances, customer advances and progress billings | 1 | 0 | 0 | |||||
| Inventory | 1 | 0 | 0 | |||||
| Disposal group, including discontinued operation | 1 | |||||||
| Assets held-for-sale, not part of disposal group | 0 | 0 | ||||||
| Other undisclosed current assets | 0 | 0 | 0 | 0 | 1 | |||
| Total current assets: | 5 | 5 | 3 | 3 | 21 | |||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 0 | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 8 | 9 | 3 | 3 | 7 | |||
| Intangible assets, net (including goodwill) | 1 | 0 | ||||||
| Intangible assets, net (excluding goodwill) | 1 | 0 | ||||||
| Disposal group, including discontinued operation, noncurrent assets | 0 | 0 | 0 | |||||
| Other undisclosed noncurrent assets | 0 | 0 | 0 | 0 | 0 | |||
| Total noncurrent assets: | 9 | 9 | 3 | 3 | 7 | |||
| TOTAL ASSETS: | 15 | 14 | 6 | 6 | 28 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 30 | 20 | 11 | 8 | 10 | |||
| Accounts payable | 14 | 8 | 4 | 3 | 4 | |||
| Accrued liabilities | 15 | 11 | 5 | 4 | 5 | |||
| Taxes payable | 1 | 1 | 2 | 1 | ||||
| Debt | 30 | 13 | 2 | 11 | 2 | |||
| Derivative instruments and hedges, liabilities | 0 | 0 | ||||||
| Due to related parties | 16 | 1 | 1 | 0 | 5 | |||
| Disposal group, including discontinued operation | 3 | 2 | 2 | |||||
| Other undisclosed current liabilities | 5 | 8 | 9 | |||||
| Total current liabilities: | 83 | 44 | 25 | 20 | 16 | |||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 0 | 4 | 2 | 5 | ||||
| Long-term debt, excluding current maturities | 4 | 3 | ||||||
| Capital lease obligations | ✕ | ✕ | 2 | 2 | ||||
| Operating lease, liability | 0 | ✕ | ✕ | ✕ | ✕ | |||
| Liabilities, other than long-term debt | 12 | 0 | 7 | |||||
| Derivative instruments and hedges, liabilities | 12 | 0 | 7 | |||||
| Other undisclosed noncurrent liabilities | 0 | (0) | ||||||
| Total noncurrent liabilities: | 0 | 0 | 16 | 2 | 13 | |||
| Total liabilities: | 84 | 44 | 41 | 21 | 29 | |||
| Temporary equity, carrying amount | 6 | |||||||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | (77) | (39) | (41) | (15) | (1) | |||
| Common stock | 1 | 0 | 0 | 0 | 0 | |||
| Additional paid in capital | 509 | 376 | 128 | 46 | 27 | |||
| Accumulated deficit | (587) | (415) | (169) | (61) | (28) | |||
| Other undisclosed stockholders' equity attributable to parent | 0 | 0 | 0 | 0 | 0 | |||
| Other undisclosed stockholders' equity | 8 | 9 | ||||||
| Total stockholders' equity: | (69) | (30) | (41) | (15) | (1) | |||
| TOTAL LIABILITIES AND EQUITY: | 15 | 14 | 6 | 6 | 28 | |||
Income statement (P&L) ($ in millions)
| 9/30/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 16 | 15 | 0 | 0 | 0 | ||
| Other income | 1 | 0 | 0 | 0 | |||
| Cost of revenue (Cost of Goods and Services Sold) | (15) | (12) | (1) | (2) | (9) | ||
| Gross profit: | 1 | 3 | (1) | (2) | (9) | ||
| Operating expenses | (32) | (28) | (21) | (38) | (64) | ||
| Other undisclosed operating income | 15 | 12 | 6 | 7 | 28 | ||
| Operating loss: | (16) | (13) | (16) | (32) | (45) | ||
| Nonoperating income (expense) | (31) | 0 | (38) | (1) | 0 | ||
| Other nonoperating income (expense) | (9) | 0 | (34) | (1) | 0 | ||
| Interest and debt expense | (10) | (22) | (9) | 0 | (3) | ||
| Loss from continuing operations before equity method investments, income taxes: | (57) | (34) | (63) | (33) | (48) | ||
| Other undisclosed income from continuing operations before income taxes | 10 | ||||||
| Loss from continuing operations before income taxes: | (47) | (34) | (63) | (33) | (48) | ||
| Income tax expense (benefit) | (1) | (1) | 1 | 9 | |||
| Loss from continuing operations: | (47) | (35) | (64) | (33) | (39) | ||
| Loss from discontinued operations | (1) | (4) | |||||
| Loss before gain (loss) on sale of properties: | (48) | (35) | (68) | (33) | (39) | ||
| Other undisclosed net income (loss) | (0) | 3 | |||||
| Net loss: | (48) | (35) | (68) | (33) | (36) | ||
| Other undisclosed net income (loss) attributable to parent | 21 | 13 | (2) | ||||
| Net loss attributable to parent: | (48) | (14) | (55) | (33) | (38) | ||
| Other undisclosed net loss available to common stockholders, basic | (124) | (232) | (53) | ||||
| Net loss available to common stockholders, diluted: | (172) | (246) | (109) | (33) | (38) | ||
Comprehensive Income ($ in millions)
| 9/30/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (48) | (35) | (68) | (33) | (36) | ||
| Comprehensive loss, net of tax, attributable to parent: | (48) | (35) | (68) | (33) | (36) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.